- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
EZH2: a novel target for cancer treatment ; volume:13 ; number:1 ; day:28 ; month:7 ; year:2020 ; pages:1-12 ; date:12.2020
Journal of hematology & oncology ; 13, Heft 1 (28.7.2020), 1-12, 12.2020
- Creator
-
Duan, Ran
Du, Wenfang
Guo, Weijian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-020-00937-8
- URN
-
urn:nbn:de:101:1-2020092319545988502544
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Duan, Ran
- Du, Wenfang
- Guo, Weijian
- SpringerLink (Online service)
Other Objects (12)
EZH2: novel therapeutic target for human cancer
Investigation of EZH2 pathways for novel epigenetic treatment strategies in oropharyngeal cancer
Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus?
SIRT7: a novel molecular target for personalized cancer treatment?
EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target
Post-translational modifications of EZH2 in cancer
TSPYL2 Regulates the Expression of EZH2 Target Genes in Neurons
Genome-wide expression analysis reveals six contravened targets of EZH2 associated with breast cancer patient survival
ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
Verification of EZH2 as a druggable target in metastatic uveal melanoma
PHGDH: a novel therapeutic target in cancer
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
EZH2: novel therapeutic target for human cancer
Investigation of EZH2 pathways for novel epigenetic treatment strategies in oropharyngeal cancer
Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus?
SIRT7: a novel molecular target for personalized cancer treatment?
EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target
Post-translational modifications of EZH2 in cancer
TSPYL2 Regulates the Expression of EZH2 Target Genes in Neurons
Genome-wide expression analysis reveals six contravened targets of EZH2 associated with breast cancer patient survival
ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
Verification of EZH2 as a druggable target in metastatic uveal melanoma
PHGDH: a novel therapeutic target in cancer
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
EZH2: novel therapeutic target for human cancer
Investigation of EZH2 pathways for novel epigenetic treatment strategies in oropharyngeal cancer
Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus?
SIRT7: a novel molecular target for personalized cancer treatment?
EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target
Post-translational modifications of EZH2 in cancer
TSPYL2 Regulates the Expression of EZH2 Target Genes in Neurons
Genome-wide expression analysis reveals six contravened targets of EZH2 associated with breast cancer patient survival
ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
Verification of EZH2 as a druggable target in metastatic uveal melanoma
PHGDH: a novel therapeutic target in cancer